首页> 外文期刊>Asia Pacific Journal of Medical Toxicology >Protective Effect of Forced Hydration with Isotonic Saline, Potassium Chloride and Magnesium Sulfate on Cisplatin Nephrotoxicity: An Initial Evaluation
【24h】

Protective Effect of Forced Hydration with Isotonic Saline, Potassium Chloride and Magnesium Sulfate on Cisplatin Nephrotoxicity: An Initial Evaluation

机译:等渗盐,氯化钾和硫酸镁强迫水合对顺铂肾毒性的保护作用:初步评价

获取原文
           

摘要

Background: Nephrotoxicity is one of the major side-effects of cisplatin that has been seen in about 20% of treated patients. The aim of this study was to assess the effectiveness of a forced hydration protocol comprised of isotonic saline, potassium chloride (KCl) and magnesium sulfate (MgSO4) on prevention of cisplatin nephrotoxicity. Methods: This cross sectional prospective study was performed on cancer patients treated in Shafa Hospital, Ahvaz, Iran from November 2009 to March 2010. The patients were under at least 50 mg/m2 cisplatin. All patients received 1000 mL isotonic saline plus 20 mEq of KCl and 2 g of MgSO4 during 2-3 hours before, and 500 mL of the same solution over the two hours after administration of cisplatin. The prescribed dose of the solution was to the extent facilitating a urine flow of at least 100 mL/h for two hours prior to chemotherapy and 2 hours post-chemotherapy. Cisplatin nephrotoxicity was defined as an increase in the SCr equal or over 0.5 mg/dL during the 5 day follow-up post-chemotherapy. Results: A total of 76 patients (48 men and 28 women with mean (SD) age of 51.0 (17.6) years) were studied. Mean cumulative cisplatin dose was 86.7 (43.1) mg/m2. Hypokalemia and hypomagnesemia were not observed in any patient. Cisplatin nephrotoxicity (increase of creatinine) was developed in 5 patients (6.6%). The mean dose of cisplatin in patients with and without nephrotoxicity was 83 and 86.97 mg respectively which showed no significant difference between them (P = 0.8). Conclusion: The new protocol was able to decrease the rate of cisplatin nephrotoxicity from about 20% to 6.6%. Further case control studies with larger sample sizes are recommended to evaluate the effectiveness of this protocol. How to cite this article: Beladi Mousavi SS, Hossainzadeh M, Khanzadeh A, Hayati F, Beladi Mousavi M, Zeraati AA, et al. Protective Effect of Forced Hydration with Isotonic Saline, Potassium Chloride and Magnesium Sulfate on Cisplatin Nephrotoxicity: An Initial Evaluation. Asia Pac J Med Toxicol 2013;2:136-9.
机译:背景:肾毒性是顺铂的主要副作用之一,已在约20%的治疗患者中发现。这项研究的目的是评估由等渗盐水,氯化钾(KCl)和硫酸镁(MgSO4)组成的强制水合方案对预防顺铂肾毒性的有效性。方法:这项横断面前瞻性研究是针对2009年11月至2010年3月在伊朗阿瓦兹(Shah)医院Shafa医院接受治疗的癌症患者进行的。患者的顺铂含量至少为50 mg / m2。所有患者在服用顺铂前2-3小时内接受1000 mL等渗盐水加20 mEq的KCl和2 g MgSO4,并在服用顺铂后的2小时内接受500 mL的相同溶液。规定剂量的溶液应在化学治疗前两个小时和化学治疗后两个小时内使尿流至少达到100 mL / h。顺铂肾毒性定义为化疗后5天随访期间SCr升高等于或超过0.5 mg / dL。结果:共研究了76名患者(48名男性和28名女性,平均(SD)年龄为51.0(17.6)岁)。顺铂的平均累积剂量为86.7(43.1)mg / m2。在任何患者中均未观察到低钾血症和低镁血症。 5例患者(6.6%)发生顺铂肾毒性(肌酐升高)。有和没有肾毒性患者的顺铂平均剂量分别为83和86.97 mg,两者之间无显着差异(P = 0.8)。结论:新方案能够将顺铂肾毒性的比率从约20%降低至6.6%。建议进行更大样本量的病例对照研究,以评估该方案的有效性。如何引用本文:Beladi Mousavi SS,Hossainzadeh M,Khanzadeh A,Hayati F,Beladi Mousavi M,Zeraati AA等。等渗盐水,氯化钾和硫酸镁的强制水合作用对顺铂肾毒性的保护作用:初步评估。 2013年Pac J Med亚太杂志; 2:136-9。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号